GGrantIndex
Sort

34,240 grants matching atherosclerosis

Signal Transduction in Atherosclerosis

$2,279,226
Garret A Fitzgerald · University Of Pennsylvania · P01 · FY2006 · HL

Non-alcoholic Fatty Liver Disease and Cardiovascular Disease in Hispanics/Latinos

$2,278,867
Jorge R Kizer · Northern California Institute/Res/Edu · R01 · FY2021 · HL

Preeclampsia to cardiovascular disease: Life course analysis of biomarkers and risk

$2,278,257
Mark A. Hlatky · Stanford University · R01 · FY2021 · HL

Integrative Neurobiology of Cardiovascular Regulation

$2,278,026
Francois M Abboud · University Of Iowa · P01 · FY2007 · HL

Integrative Neurobiology of Cardiovascular Regulation

$2,277,752
University Of Iowa · P01 · FY2005 · HL

HDL Structure and its Function in Atherosclerosis

$2,277,257
Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · P01 · FY2014 · HL

Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease

$2,275,272
Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI

Membrane-Mediated Alterations in Diabetes

$2,273,670
Richard W Gross · Washington University · P01 · FY2008 · HL

IGF::OT::IGF Jackson Heart Study Renewal Coordinating Center

$2,273,113
Adolfo Correa · University Of Mississippi Med Ctr · N01 · FY2014 · HL

Identifying the gene networks of insulin resistance: the GENESIPS study

$2,272,407
Thomas None Quertermous · Stanford University · U01 · FY2015 · HL

Non-alcoholic Fatty Liver Disease and Cardiovascular Disease in Hispanics/Latinos

$2,271,824
Jorge R Kizer · Northern California Institute/Res/Edu · R01 · FY2022 · HL

MOLECULAR GENETIC APPROCHES IN ATHEROSCLEROSIS RESEARCH

$2,271,296
University Of California Los Angeles · P01 · FY2003 · HL

Effect of Age on Antibody Diversity

$2,267,623
Patricia J. Gearhart · National Institute On Aging · ZIA · FY2018 · AG

Identifying the gene networks of insulin resistance: the GENESIPS study

$2,267,492
Thomas None Quertermous · Stanford University · U01 · FY2014 · HL

Preeclampsia to cardiovascular disease: Life course analysis of biomarkers and risk

$2,267,445
Mark A. Hlatky · Stanford University · R01 · FY2018 · HL

NHLBI Animal Program Division

$2,267,314
James Hawkins · National Heart, Lung, And Blood Institute · ZIG · FY2015 · HL

Redox regulation of cellular information processing

$2,264,802
Melissa Lambeth Kemp · Georgia Institute Of Technology · DP2 · FY2009 · OD

Novel commensal polysaccharide treats multiple sclerosis through Treg modulation

$2,264,726
Lloyd H Kasper · Symbiotix Biotherapies, Inc. · R42 · FY2015 · AI

Biobehavioral Bases of CHD Risk and Management

$2,264,408
Neil Schneiderman · University Of Miami Coral Gables · P01 · FY2009 · HL

Nanotechnology: Detection & Analysis of Plaque Formation

$2,264,225
Gang Bao · Emory University · U01 · FY2008 · HL

Endothelial Metabolism and Redox Imbalance in Vascular Disease

$2,264,097
Tohru Fukai · Augusta University · P01 · FY2025 · HL

Endothelial Metabolism and Redox Imbalance in Vascular Disease

$2,264,097
Tohru Fukai · Augusta University · P01 · FY2024 · HL

Biobehavioral Bases of CHD Risk and Management

$2,261,466
Neil Schneiderman · University Of Miami Coral Gables · P01 · FY2010 · HL

Modifiable Drivers of Expansion and Malignant Transformation from Clonal Hematopoiesis

$2,261,447
Margaret Goodell · Baylor College Of Medicine · P01 · FY2025 · CA

INTEGRATIVE NEUROBIOLOGY OF CARDIOVASCULAR REGULATION

$2,259,861
Francois M Abboud · University Of Iowa · P01 · FY2012 · HL